Because of your will and generous support, CDF is beginning to move the diagnosis needle for celiac disease and gluten sensitivity. We have seen progress through our efforts in Research, Education, Advocacy and Awareness. Please take a look at our "Year in Review" to see the impact your support has made.
Continue ReadingCeliac Disease Foundation (CDF) launched the nation’s most comprehensive online directory for patients to find reliable information on healthcare practitioners familiar with diagnosing and treating celiac disease and other gluten-related…
Continue ReadingFDA clarifies what the Gluten-Free Labeling Rule means for restaurants - considers enforcement action to protect consumers
Continue ReadingAlvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the first randomized study patient was dosed in the CeliAction Study™
Continue ReadingKathy Giusti, CEO of the Multiple Myeloma Research Foundation (MMRF). Marilyn Geller, CEO of the Celiac Disease Foundation (CDF). What do these women have in common? They are leading dynamic,…
Continue Reading[video width="600" height="200" mp4="/wp-content/uploads/2024/09/ICDS-2024-header-recap.mp4" poster="/wp-content/uploads/2024/09/ICDS-2024-header-recap.jpg"][/video] Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller led the End Points in Clinical Trials session, where...